2024 annual financial data
Atea Pharmaceuticals 2024 Net income growth
Direct answer
Net income growth was -23.85%.
Operating income was -192,950,000 USD and net income was -168,385,000 USD.
Operating cash flow was -135,499,000 USD.
Get free Atea Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -192,950,000 USD
- Net income
- -168,385,000 USD
- Operating cash flow
- -135,499,000 USD